Long term breast cancer screening in Nijmegen, The Netherlands: The nine rounds from 1975-92

Journal of Epidemiology and Community Health

Volumn 50, Issue 3, 1996, Pages 353-358

  Otten, Johannes D M ^a   Van Dijck, Jos A A M ^a   Peer, Petronella G M ^a   Straatman, Huub ^a   Verbeek, André L M ^a   Mravunac, Marcel ^b   Hendriks, Jan H C L ^c   Holland, Roland ^c  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER MORTALITY; CANCER SCREENING; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; NETHERLANDS; NORMAL HUMAN; PATIENT REFERRAL;

EID: 0029943935     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.50.3.353     Document Type: Article

References (26)

1. Shapiro S, Venet W, Strax P, Venet L. Current results of the breast cancer screening randomized trial: the Health Insurance Plan (HIP) of greater New York. In: Day NE, Miller AB eds. Screening for breast cancer. Toronto: Hans Huber Publishers, 1988:3-15.
2. Rutqvist LE, Miller AB, Andersson I, et al. Reduced breast-cancer mortality with mammography screening - an assessment of currently available data. Int J Cancer 1990;5 (suppl):76-84.
3. Wald N, Frost C, Cuckle H. Breast cancer screening: the current position. BMJ 1991;302:845-6.
4. Tabàr L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
5. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341:973-8.
6. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 1993;85:1644-56.
7. Peeters PHM, Verbeek ALM, Hendriks JHCL, Van Bon MJH. Screening for breast cancer in Nijmegen. Report of 6 screening rounds, 1975-1986. Int J Cancer 1989;43: 226-30.
8. Brecht JG, Robra BP. A graphic method of estimating the specificity of screening programmes from incomplete follow-up data. Methods Inf Med 1987;26:53-8.
9. Day NE, Williams DRR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989;59:954-8.
10. Van Dijck JAAM, Holland R, Verbeek ALM, Hendriks JHCL, Mravunac M. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen Program in The Netherlands. J Natl Cancer Inst 1994;86: 934-8.
11. Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F, Day NE. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet 1984; i:1222-4.
12. Day NE, Walter SD, Tabár L, Fagerberg CJG, Collette HJA. The sensitivity and lead time of breast cancer screening: a comparison of the results of different studies. In: Day NE, Miller AB (eds.). Screening for breast cancer. Toronto: Hans Huber Publishers, 1988:105-9.
13. Kopans DB. Mammography screening for breast cancer. Cancer 1993;72:1809-12.
14. Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology 1986;161:37-41.
15. Van Dijck JAAM, Verbeek ALM, Hendriks JHCL, Holland R. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer 1993;72:1933-8.
16. Chamberlain J, Moss SM, Kirkpatrick AE, Michell M, Johns L. National Health Service breast screening programme results for 1991-2. BMJ 1993;307:353-6.
17. American Cancer Society. The breast cancer detection demonstration project five year summary report, Ca Cancer J Clin 1982;32:194-256.
18. Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49-56.
19. Woodman CBJ, Threlfall AG, Boggis CRM, Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 1995;310:224-6.
20. Anderson TJ, Lamb J, Donnan P, et al. Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer 1991;64:108-13.
21. Paci E, Ciatto S, Buiatti E, Cecchini S, Palli D, Rosselli Del Turco M. Early indicators of efficacy of breast cancer screening programmes. Results of the Florence district programme. Int J Cancer 1990;46:198-202.
22. Peeters PHM, Verbeek ALM, Zielhuis GA, Vooijs GP, Hendriks JHCL, Mravunac M. Breast cancer screening in women over age 50. A critical appraisal. Acta Radiol 1990;31: 225-31.
23. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994;11:167-80
24. Holland R, Conolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113-8.
25. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993; 328:1581-6.
26. De Koning HJ, Boer R, Van Ineveld BM, et al. Landelijke evaluatie van bevolkingsonderzoek naar borstkanker in Nedenand (in Dutch) Rotterdam: Instituut Maatschappelijke Gezondheidszorg, Erasmus Universiteit Rotterdam, 1993.